nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—SLCO1A2—Prednisone—Crohn's disease	0.298	0.512	CbGbCtD
Erythromycin—CYP3A5—Sulfasalazine—Crohn's disease	0.155	0.266	CbGbCtD
Erythromycin—ABCB1—Prednisone—Crohn's disease	0.0806	0.138	CbGbCtD
Erythromycin—CYP3A4—Prednisone—Crohn's disease	0.0483	0.083	CbGbCtD
Erythromycin—MLNR—smooth muscle tissue—Crohn's disease	0.028	0.393	CbGeAlD
Erythromycin—MLNR—digestive system—Crohn's disease	0.0221	0.311	CbGeAlD
Erythromycin—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0131	0.0604	CbGpPWpGaD
Erythromycin—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0131	0.0604	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00725	0.0334	CbGpPWpGaD
Erythromycin—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.00716	0.0554	CcSEcCtD
Erythromycin—MLNR—G alpha (q) signalling events—MLN—Crohn's disease	0.00696	0.0321	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00687	0.0316	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.00622	0.0287	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00567	0.0261	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00486	0.0224	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00476	0.0219	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00461	0.0212	CbGpPWpGaD
Erythromycin—MLNR—G alpha (q) signalling events—GPR65—Crohn's disease	0.00448	0.0207	CbGpPWpGaD
Erythromycin—Abdominal cramps—Mesalazine—Crohn's disease	0.00444	0.0344	CcSEcCtD
Erythromycin—Nephritis interstitial—Mesalazine—Crohn's disease	0.00444	0.0344	CcSEcCtD
Erythromycin—Burning sensation—Mesalazine—Crohn's disease	0.00432	0.0334	CcSEcCtD
Erythromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00428	0.0197	CbGpPWpGaD
Erythromycin—Hepatotoxicity—Azathioprine—Crohn's disease	0.00427	0.033	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00401	0.0185	CbGpPWpGaD
Erythromycin—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.00392	0.0303	CcSEcCtD
Erythromycin—Hepatotoxicity—Mesalazine—Crohn's disease	0.00389	0.0301	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00373	0.0172	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—ACKR2—Crohn's disease	0.0037	0.0171	CbGpPWpGaD
Erythromycin—SLC22A7—digestive system—Crohn's disease	0.00364	0.0512	CbGeAlD
Erythromycin—MLNR—GPCR ligand binding—MLN—Crohn's disease	0.00351	0.0162	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00347	0.016	CbGpPWpGaD
Erythromycin—Tenderness—Mesalazine—Crohn's disease	0.00344	0.0266	CcSEcCtD
Erythromycin—Pancreatitis—Mercaptopurine—Crohn's disease	0.0034	0.0263	CcSEcCtD
Erythromycin—Trauma—Prednisone—Crohn's disease	0.00333	0.0258	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00319	0.0147	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00315	0.0145	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00297	0.0137	CbGpPWpGaD
Erythromycin—Skin exfoliation—Mesalazine—Crohn's disease	0.00286	0.0222	CcSEcCtD
Erythromycin—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00274	0.0212	CcSEcCtD
Erythromycin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00263	0.0121	CbGpPWpGaD
Erythromycin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00263	0.0121	CbGpPWpGaD
Erythromycin—SLCO1A2—Transport of organic anions—ALB—Crohn's disease	0.00251	0.0115	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00247	0.0114	CbGpPWpGaD
Erythromycin—Deafness—Mesalazine—Crohn's disease	0.00243	0.0188	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CCR9—Crohn's disease	0.00243	0.0112	CbGpPWpGaD
Erythromycin—MLNR—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00232	0.0107	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—GPR65—Crohn's disease	0.00226	0.0104	CbGpPWpGaD
Erythromycin—SLCO1A2—digestive system—Crohn's disease	0.00221	0.031	CbGeAlD
Erythromycin—ABCC1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00219	0.0101	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00217	0.01	CbGpPWpGaD
Erythromycin—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00215	0.0167	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00212	0.00975	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00207	0.00955	CbGpPWpGaD
Erythromycin—ABCC1—mammalian vulva—Crohn's disease	0.00206	0.029	CbGeAlD
Erythromycin—Pancreatitis—Azathioprine—Crohn's disease	0.00203	0.0157	CcSEcCtD
Erythromycin—Liver function test abnormal—Mesalazine—Crohn's disease	0.00201	0.0156	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—MLN—Crohn's disease	0.00198	0.00914	CbGpPWpGaD
Erythromycin—Abdominal discomfort—Azathioprine—Crohn's disease	0.00198	0.0153	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—ACKR2—Crohn's disease	0.0019	0.00875	CbGpPWpGaD
Erythromycin—Anorexia—Mercaptopurine—Crohn's disease	0.00188	0.0145	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00186	0.00858	CbGpPWpGaD
Erythromycin—SLCO1A2—Recycling of bile acids and salts—ALB—Crohn's disease	0.00186	0.00856	CbGpPWpGaD
Erythromycin—Pancreatitis—Mesalazine—Crohn's disease	0.00185	0.0143	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00183	0.0141	CcSEcCtD
Erythromycin—Abdominal discomfort—Mesalazine—Crohn's disease	0.0018	0.014	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—MLN—Crohn's disease	0.0018	0.0083	CbGpPWpGaD
Erythromycin—CYP2B6—skin of body—Crohn's disease	0.00173	0.0243	CbGeAlD
Erythromycin—Decreased appetite—Mercaptopurine—Crohn's disease	0.00171	0.0133	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00166	0.0129	CcSEcCtD
Erythromycin—Jaundice—Mesalazine—Crohn's disease	0.00164	0.0127	CcSEcCtD
Erythromycin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00164	0.00753	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CCR6—Crohn's disease	0.00161	0.00742	CbGpPWpGaD
Erythromycin—Erythema multiforme—Azathioprine—Crohn's disease	0.00156	0.0121	CcSEcCtD
Erythromycin—Skin exfoliation—Prednisone—Crohn's disease	0.00152	0.0117	CcSEcCtD
Erythromycin—Hepatitis—Mesalazine—Crohn's disease	0.00151	0.0117	CcSEcCtD
Erythromycin—Arrhythmia—Azathioprine—Crohn's disease	0.00148	0.0114	CcSEcCtD
Erythromycin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00145	0.0112	CcSEcCtD
Erythromycin—CYP1A2—digestive system—Crohn's disease	0.00144	0.0203	CbGeAlD
Erythromycin—Erythema multiforme—Mesalazine—Crohn's disease	0.00142	0.011	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—PTGER4—Crohn's disease	0.00142	0.00653	CbGpPWpGaD
Erythromycin—Tinnitus—Mesalazine—Crohn's disease	0.0014	0.0109	CcSEcCtD
Erythromycin—CYP2B6—lymphoid tissue—Crohn's disease	0.0014	0.0197	CbGeAlD
Erythromycin—CYP3A5—digestive system—Crohn's disease	0.00139	0.0195	CbGeAlD
Erythromycin—CYP2B6—digestive system—Crohn's disease	0.00138	0.0194	CbGeAlD
Erythromycin—MLNR—GPCR downstream signaling—CCR9—Crohn's disease	0.00137	0.00633	CbGpPWpGaD
Erythromycin—Diarrhoea—Mercaptopurine—Crohn's disease	0.00135	0.0104	CcSEcCtD
Erythromycin—Erythema—Mesalazine—Crohn's disease	0.00131	0.0101	CcSEcCtD
Erythromycin—Dysgeusia—Mesalazine—Crohn's disease	0.00128	0.00994	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—GPR65—Crohn's disease	0.00128	0.00589	CbGpPWpGaD
Erythromycin—ABCC1—S1P1 pathway—PTGS2—Crohn's disease	0.00127	0.00587	CbGpPWpGaD
Erythromycin—Vomiting—Mercaptopurine—Crohn's disease	0.00125	0.0097	CcSEcCtD
Erythromycin—Injury—Prednisone—Crohn's disease	0.00125	0.0097	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCR9—Crohn's disease	0.00125	0.00575	CbGpPWpGaD
Erythromycin—Rash—Mercaptopurine—Crohn's disease	0.00124	0.00962	CcSEcCtD
Erythromycin—Discomfort—Azathioprine—Crohn's disease	0.00121	0.00937	CcSEcCtD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00119	0.0055	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00119	0.0055	CbGpPWpGaD
Erythromycin—Vertigo—Mesalazine—Crohn's disease	0.00118	0.00912	CcSEcCtD
Erythromycin—Nausea—Mercaptopurine—Crohn's disease	0.00117	0.00906	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—GPR65—Crohn's disease	0.00116	0.00535	CbGpPWpGaD
Erythromycin—Palpitations—Mesalazine—Crohn's disease	0.00116	0.00897	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—ACKR2—Crohn's disease	0.00112	0.00517	CbGpPWpGaD
Erythromycin—Chest pain—Mesalazine—Crohn's disease	0.00112	0.00864	CcSEcCtD
Erythromycin—Discomfort—Mesalazine—Crohn's disease	0.0011	0.00854	CcSEcCtD
Erythromycin—Irritability—Prednisone—Crohn's disease	0.0011	0.00851	CcSEcCtD
Erythromycin—Confusional state—Mesalazine—Crohn's disease	0.00108	0.00835	CcSEcCtD
Erythromycin—Anaphylactic shock—Mesalazine—Crohn's disease	0.00107	0.00828	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—MLN—Crohn's disease	0.00106	0.0049	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00106	0.00487	CbGpPWpGaD
Erythromycin—CYP3A4—digestive system—Crohn's disease	0.00104	0.0147	CbGeAlD
Erythromycin—ABCC1—lymph node—Crohn's disease	0.00103	0.0145	CbGeAlD
Erythromycin—Anorexia—Mesalazine—Crohn's disease	0.00102	0.00789	CcSEcCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00102	0.00468	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00101	0.00465	CbGpPWpGaD
Erythromycin—Pancreatitis—Prednisone—Crohn's disease	0.000977	0.00755	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—TAGAP—Crohn's disease	0.000973	0.00448	CbGpPWpGaD
Erythromycin—ABCB1—epithelium—Crohn's disease	0.000971	0.0136	CbGeAlD
Erythromycin—SLCO1A2—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000971	0.00447	CbGpPWpGaD
Erythromycin—Feeling abnormal—Azathioprine—Crohn's disease	0.000968	0.00749	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.000963	0.00444	CbGpPWpGaD
Erythromycin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000961	0.00744	CcSEcCtD
Erythromycin—Decreased appetite—Mesalazine—Crohn's disease	0.000931	0.0072	CcSEcCtD
Erythromycin—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.00093	0.00428	CbGpPWpGaD
Erythromycin—Abdominal pain—Azathioprine—Crohn's disease	0.000929	0.00719	CcSEcCtD
Erythromycin—Pain—Mesalazine—Crohn's disease	0.000915	0.00708	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—CCR6—Crohn's disease	0.000911	0.00419	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00089	0.0041	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00089	0.0041	CbGpPWpGaD
Erythromycin—Feeling abnormal—Mesalazine—Crohn's disease	0.000882	0.00682	CcSEcCtD
Erythromycin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000875	0.00677	CcSEcCtD
Erythromycin—Hypersensitivity—Azathioprine—Crohn's disease	0.000866	0.0067	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—RSPO3—Crohn's disease	0.00085	0.00392	CbGpPWpGaD
Erythromycin—Urticaria—Mesalazine—Crohn's disease	0.00085	0.00658	CcSEcCtD
Erythromycin—Abdominal pain—Mesalazine—Crohn's disease	0.000846	0.00655	CcSEcCtD
Erythromycin—ABCB1—mammalian vulva—Crohn's disease	0.000843	0.0118	CbGeAlD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000841	0.00387	CbGpPWpGaD
Erythromycin—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00083	0.00382	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CCR6—Crohn's disease	0.000827	0.00381	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SEL1L—Crohn's disease	0.000806	0.00371	CbGpPWpGaD
Erythromycin—Diarrhoea—Azathioprine—Crohn's disease	0.000804	0.00622	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—PTGER4—Crohn's disease	0.000802	0.00369	CbGpPWpGaD
Erythromycin—Hallucination—Prednisone—Crohn's disease	0.000793	0.00614	CcSEcCtD
Erythromycin—Hypersensitivity—Mesalazine—Crohn's disease	0.000789	0.0061	CcSEcCtD
Erythromycin—Dizziness—Azathioprine—Crohn's disease	0.000777	0.00601	CcSEcCtD
Erythromycin—Pruritus—Mesalazine—Crohn's disease	0.000757	0.00586	CcSEcCtD
Erythromycin—ABCB1—lymphoid tissue—Crohn's disease	0.000748	0.0105	CbGeAlD
Erythromycin—Vomiting—Azathioprine—Crohn's disease	0.000747	0.00578	CcSEcCtD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000743	0.00342	CbGpPWpGaD
Erythromycin—Rash—Azathioprine—Crohn's disease	0.000741	0.00573	CcSEcCtD
Erythromycin—ABCB1—digestive system—Crohn's disease	0.000739	0.0104	CbGeAlD
Erythromycin—MLNR—Signaling Pathways—CCR9—Crohn's disease	0.000737	0.0034	CbGpPWpGaD
Erythromycin—Diarrhoea—Mesalazine—Crohn's disease	0.000732	0.00567	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—PTGER4—Crohn's disease	0.000728	0.00335	CbGpPWpGaD
Erythromycin—Arrhythmia—Prednisone—Crohn's disease	0.000712	0.00551	CcSEcCtD
Erythromycin—Dizziness—Mesalazine—Crohn's disease	0.000708	0.00548	CcSEcCtD
Erythromycin—CYP3A7—Metapathway biotransformation—GPX4—Crohn's disease	0.0007	0.00322	CbGpPWpGaD
Erythromycin—Nausea—Azathioprine—Crohn's disease	0.000698	0.0054	CcSEcCtD
Erythromycin—Erythema—Prednisone—Crohn's disease	0.000694	0.00537	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—GPR65—Crohn's disease	0.000686	0.00316	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—IL3—Crohn's disease	0.000683	0.00315	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000682	0.00314	CbGpPWpGaD
Erythromycin—Vomiting—Mesalazine—Crohn's disease	0.000681	0.00527	CcSEcCtD
Erythromycin—Rash—Mesalazine—Crohn's disease	0.000675	0.00522	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00066	0.00304	CbGpPWpGaD
Erythromycin—Nausea—Mesalazine—Crohn's disease	0.000636	0.00492	CcSEcCtD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000627	0.00289	CbGpPWpGaD
Erythromycin—Vertigo—Prednisone—Crohn's disease	0.000624	0.00482	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—IL3—Crohn's disease	0.00062	0.00286	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000606	0.00279	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000606	0.00279	CbGpPWpGaD
Erythromycin—Convulsion—Prednisone—Crohn's disease	0.000601	0.00465	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—RASGRP1—Crohn's disease	0.0006	0.00276	CbGpPWpGaD
Erythromycin—ABCC1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000588	0.00271	CbGpPWpGaD
Erythromycin—Discomfort—Prednisone—Crohn's disease	0.000584	0.00452	CcSEcCtD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000579	0.00267	CbGpPWpGaD
Erythromycin—Anaphylactic shock—Prednisone—Crohn's disease	0.000566	0.00438	CcSEcCtD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00056	0.00258	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000554	0.00255	CbGpPWpGaD
Erythromycin—Anorexia—Prednisone—Crohn's disease	0.00054	0.00418	CcSEcCtD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000533	0.00246	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CXCL8—Crohn's disease	0.000519	0.00239	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—GPX4—Crohn's disease	0.000517	0.00238	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000517	0.00238	CbGpPWpGaD
Erythromycin—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000511	0.00236	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000506	0.00233	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.000506	0.00233	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000504	0.00232	CbGpPWpGaD
Erythromycin—Decreased appetite—Prednisone—Crohn's disease	0.000492	0.00381	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—CCR6—Crohn's disease	0.000488	0.00225	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—IL2RA—Crohn's disease	0.000478	0.0022	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000476	0.00219	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.00047	0.00217	CbGpPWpGaD
Erythromycin—Feeling abnormal—Prednisone—Crohn's disease	0.000467	0.00361	CcSEcCtD
Erythromycin—Gastrointestinal pain—Prednisone—Crohn's disease	0.000463	0.00358	CcSEcCtD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000452	0.00208	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000452	0.00208	CbGpPWpGaD
Erythromycin—Urticaria—Prednisone—Crohn's disease	0.00045	0.00348	CcSEcCtD
Erythromycin—Abdominal pain—Prednisone—Crohn's disease	0.000448	0.00346	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—RBX1—Crohn's disease	0.000442	0.00204	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL2RA—Crohn's disease	0.000434	0.002	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PTGER4—Crohn's disease	0.00043	0.00198	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000428	0.00197	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000427	0.00197	CbGpPWpGaD
Erythromycin—ABCB1—lymph node—Crohn's disease	0.000422	0.00593	CbGeAlD
Erythromycin—Hypersensitivity—Prednisone—Crohn's disease	0.000417	0.00323	CcSEcCtD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000407	0.00188	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000407	0.00188	CbGpPWpGaD
Erythromycin—Pruritus—Prednisone—Crohn's disease	0.000401	0.0031	CcSEcCtD
Erythromycin—Diarrhoea—Prednisone—Crohn's disease	0.000388	0.003	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—UBE2D1—Crohn's disease	0.000387	0.00178	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000382	0.00176	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000378	0.00174	CbGpPWpGaD
Erythromycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	0.000377	0.00174	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—RIPK2—Crohn's disease	0.000376	0.00173	CbGpPWpGaD
Erythromycin—Dizziness—Prednisone—Crohn's disease	0.000375	0.0029	CcSEcCtD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000371	0.00171	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL3—Crohn's disease	0.000366	0.00169	CbGpPWpGaD
Erythromycin—Vomiting—Prednisone—Crohn's disease	0.00036	0.00279	CcSEcCtD
Erythromycin—Rash—Prednisone—Crohn's disease	0.000357	0.00276	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—RASGRP1—Crohn's disease	0.000354	0.00163	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000347	0.0016	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000344	0.00158	CbGpPWpGaD
Erythromycin—Nausea—Prednisone—Crohn's disease	0.000336	0.0026	CcSEcCtD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000334	0.00154	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—JAK2—Crohn's disease	0.000321	0.00148	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SOCS1—Crohn's disease	0.000321	0.00148	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000319	0.00147	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000312	0.00144	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000307	0.00141	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—TYK2—Crohn's disease	0.000306	0.00141	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000305	0.0014	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CXCL8—Crohn's disease	0.000293	0.00135	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—JAK2—Crohn's disease	0.000292	0.00134	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000287	0.00132	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000282	0.0013	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SMAD3—Crohn's disease	0.000277	0.00128	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000268	0.00123	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CXCL8—Crohn's disease	0.000266	0.00123	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL2RA—Crohn's disease	0.000257	0.00118	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000254	0.00117	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PLA2G4F—Crohn's disease	0.000249	0.00115	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000249	0.00115	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000239	0.0011	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000235	0.00108	CbGpPWpGaD
Erythromycin—ABCC1—Disease—RSPO3—Crohn's disease	0.000234	0.00108	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PLA2G4F—Crohn's disease	0.000224	0.00103	CbGpPWpGaD
Erythromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000223	0.00103	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000222	0.00102	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SEL1L—Crohn's disease	0.000222	0.00102	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000216	0.000995	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—MTMR3—Crohn's disease	0.000212	0.000976	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000202	0.000932	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.0002	0.00092	CbGpPWpGaD
Erythromycin—ABCC1—Disease—LTF—Crohn's disease	0.000199	0.000917	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	0.000196	0.000901	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000194	0.000892	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000194	0.000892	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000191	0.000881	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—MTMR3—Crohn's disease	0.000191	0.000878	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000188	0.000866	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TYK2—Crohn's disease	0.000181	0.000833	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.00018	0.000831	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—JAK2—Crohn's disease	0.000172	0.000795	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—MTMR3—Crohn's disease	0.000166	0.000766	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—FADS1—Crohn's disease	0.000165	0.00076	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000163	0.000749	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000161	0.000742	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.000161	0.000742	CbGpPWpGaD
Erythromycin—ABCC1—Disease—GCKR—Crohn's disease	0.00016	0.000739	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL8—Crohn's disease	0.000157	0.000725	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GPX4—Crohn's disease	0.000155	0.000712	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL6—Crohn's disease	0.00015	0.00069	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GCKR—Crohn's disease	0.000149	0.000688	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—FADS1—Crohn's disease	0.000149	0.000684	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	0.000145	0.000666	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SLC11A1—Crohn's disease	0.000142	0.000653	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	0.000141	0.000651	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GPX4—Crohn's disease	0.000139	0.000641	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000136	0.000629	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000136	0.000626	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GCKR—Crohn's disease	0.000134	0.000619	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.000131	0.000603	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—FADS1—Crohn's disease	0.00013	0.000597	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000127	0.000584	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—STAT3—Crohn's disease	0.000127	0.000583	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—MTMR3—Crohn's disease	0.000123	0.000567	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HSPA1B—Crohn's disease	0.000122	0.00056	CbGpPWpGaD
Erythromycin—ABCC1—Disease—RBX1—Crohn's disease	0.000122	0.00056	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GPX4—Crohn's disease	0.000121	0.000559	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000121	0.000556	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—MTMR3—Crohn's disease	0.00012	0.000554	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000119	0.000546	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GCKR—Crohn's disease	0.000117	0.00054	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000107	0.000492	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.000107	0.000491	CbGpPWpGaD
Erythromycin—ABCC1—Disease—UBE2D1—Crohn's disease	0.000107	0.000491	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000101	0.000467	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.6e-05	0.000442	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—FADS1—Crohn's disease	9.58e-05	0.000441	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	9.57e-05	0.000441	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—FADS1—Crohn's disease	9.37e-05	0.000431	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.33e-05	0.00043	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	9.13e-05	0.000421	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—MTMR3—Crohn's disease	9.07e-05	0.000418	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GPX4—Crohn's disease	8.97e-05	0.000413	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL6—Crohn's disease	8.84e-05	0.000407	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GPX4—Crohn's disease	8.77e-05	0.000404	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GCKR—Crohn's disease	8.67e-05	0.000399	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	8.52e-05	0.000392	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GCKR—Crohn's disease	8.47e-05	0.00039	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.4e-05	0.000387	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SMAD3—Crohn's disease	7.63e-05	0.000351	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—MTMR3—Crohn's disease	7.24e-05	0.000334	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—FADS1—Crohn's disease	7.07e-05	0.000326	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GPX4—Crohn's disease	6.62e-05	0.000305	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	6.57e-05	0.000303	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	6.46e-05	0.000298	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GCKR—Crohn's disease	6.39e-05	0.000294	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—FADS1—Crohn's disease	5.64e-05	0.00026	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.59e-05	0.000257	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GPX4—Crohn's disease	5.28e-05	0.000243	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GCKR—Crohn's disease	5.1e-05	0.000235	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TYK2—Crohn's disease	4.98e-05	0.000229	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ALB—Crohn's disease	4.75e-05	0.000219	CbGpPWpGaD
Erythromycin—ABCC1—Disease—JAK2—Crohn's disease	4.75e-05	0.000219	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CD4—Crohn's disease	4.5e-05	0.000207	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTGS2—Crohn's disease	4.47e-05	0.000206	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—FADS1—Crohn's disease	4.35e-05	0.000201	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.34e-05	0.0002	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ALB—Crohn's disease	4.28e-05	0.000197	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTGS2—Crohn's disease	4.16e-05	0.000191	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GPX4—Crohn's disease	4.08e-05	0.000188	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GCKR—Crohn's disease	3.94e-05	0.000181	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTGS2—Crohn's disease	3.74e-05	0.000172	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ALB—Crohn's disease	3.73e-05	0.000172	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.65e-05	0.000168	CbGpPWpGaD
Erythromycin—ABCC1—Disease—STAT3—Crohn's disease	3.48e-05	0.00016	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTGS2—Crohn's disease	3.26e-05	0.00015	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.19e-05	0.000147	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ALB—Crohn's disease	2.76e-05	0.000127	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ALB—Crohn's disease	2.7e-05	0.000124	CbGpPWpGaD
Erythromycin—ABCC1—Disease—IL6—Crohn's disease	2.43e-05	0.000112	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTGS2—Crohn's disease	2.41e-05	0.000111	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTGS2—Crohn's disease	2.36e-05	0.000109	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ALB—Crohn's disease	2.03e-05	9.37e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTGS2—Crohn's disease	1.78e-05	8.2e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ALB—Crohn's disease	1.62e-05	7.48e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.42e-05	6.54e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ALB—Crohn's disease	1.25e-05	5.77e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.1e-05	5.05e-05	CbGpPWpGaD
